1-3 of 3
Heba Ismail
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Brandon M. Nathan, Maria J. Redondo, Heba Ismail, Laura Jacobsen, Emily K. Sims, Jerry Palmer, Jay Skyler, Laura Bocchino, Susan Geyer, Jay M. Sosenko
Journal: Diabetes Care
Diabetes Care 2022;45(2):311–318
https://doi.org/10.2337/dc21-0944
Published: 01 December 2021
View article titled, Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes
Open the PDF for Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes in another window
Journal Articles

A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes

Strategies to Enhance New CGM Use in Early Childhood (SENCE) Study Group, Lori Laffel, Kara Harrington, Anat Hanono, Nisha Naik, Louise Ambler-Osborn, Alan Schultz, Linda DiMeglio, Stephanie Woerne, Heather Jolivette, Heba Ismail, Megan Tebbe, America Newman, Megan Legge, William Tamborlane, Michelle Van Name, Kate Weyman, Jennifer Finnegan, Amy Steffen, Melinda Zgorski, Daniel DeSalvo, Marisa Hilliard, Kylie DeLaO, Cicilyn Xie, Wendy Levy, R. Paul Wadwa, Greg Forlenza, Shideh Majidi, Guy Alonso, Isabel Weber, Michelle Clay, Emily Simmons, Brandon Nathan, Muna Sunni, Jessica Sweet, Beth Pappenfus, Anne Kogler, Marrissa Ludwig, Brittney Nelson, Anne Street, Darcy Weingartner, Anastasia Albanese-O’Neill, Michael Haller, Janey Adams, Miriam Cintron, Nicole Thomas, Jennifer Kelley, Jill Simmons, George William, Faith Brendle, Robin Goland, Kristen Williams, Rachelle Gandica, Sarah Pollak, Emily Casciano, Elizabeth Robinson, Steven Willi, Pantea Minnock, Diana Olivos, Cathy Carchidi, Brian Grant, Jenise C. Wong, Saleh Adi, Sarah Corathers, Nicole Sheanon, Cathy Fox, Tammy Weis, Sarah MacLeish, Jamie Wood, Terri Casey, Wendy Campbell, Paul McGuigan, Kupper Wintergerst, Sara Watson, Suzanne Kingery, Gwen Pierce, Heather Ruch, Lauren Rayborn, Manuel Rodriguez-Luna, Amy Deuser
Journal: Diabetes Care
Diabetes Care 2021;44(2):464–472
https://doi.org/10.2337/dc20-1060
Published: 17 December 2020
View article titled, A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes
Open the PDF for A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes in another window
Journal Articles

Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients

Barbara M. Brooks-Worrell, PHD, Jessica L. Reichow, BS, Amit Goel, MD, Heba Ismail, MD, Jerry P. Palmer, MD
Journal: Diabetes Care
Diabetes Care 2011;34(1):168–173
https://doi.org/10.2337/dc10-0579
Published: 20 September 2010
View article titled, Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Open the PDF for Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients in another window